Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Zinc
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly Epiome.AI (epiome.ai)
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

A first-in-class neurotherapeutic discovery platform that decodes blood to reveal the biology of the living brain, and targets the causes of neurodegenerative disease.